Clinical trial

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

NCT02053142

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Acyclovir Normalized identity: acyclovirView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhaseNA

Conditions

Ulcers of Female Genital Organsunresolved

Interventions

AcyclovirDRUG · verified · RxNorm: acyclovir

PlaceboDRUG

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02053142 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.